Thoma Bravo’s Tse: LOGEX growth could help mesh European healthcare

LOGEX is the first investment by Thoma Bravo’s London-based European team.

ByCraig McGlashan

7 March 2023•2 mins read

[data-article-body-skeleton]{display:none!important}

JavaScript is required to read this article. Please enable it in your browser and reload the page.

Healthcare Top Stories

Dealmakers bullish on UK post-Budget; Polaris Growth Fund backs aerial drones biz; Exponent to carve out flow control company

9 hours ago · 5 mins read

Private equity in the UK: GPs see 'very strong' deal pipeline post-Budget

11 hours ago · 8 mins read

Orangewood forms THRM platform, acquires RSG in 'fragmented' foodservice industry; Hg’s Chris Kindt on AI-proofing software pricing

28 October 2026 · 6 mins read

Blue Point’s Weaver Brands finds strong fit, attractive market with Shapley’s

28 October 2026 · 3 mins read

Hg's Chris Kindt says the firm's software companies needed to AI-proof their pricing

28 October 2026 · 3 mins read

Gemspring’s Shrieve Chemical acquires UK drilling fluids maker Clear Solutions

28 October 2026 · 1 min read

Eurazeo’s CEO Christophe Bavière shares mid-market strategy; Leon Capital to invest in data center infra company VKE; Truelink to carve out Johnson Controls’ intrusion products business

27 October 2026 · 5 mins read

Thoma Bravo’s Tse: LOGEX growth could help mesh European healthcare

Related articles